Although the global diagnostic market of cardiac biomarkers remains heterogeneous, many convincing evidences were brought that there is no reliable alternative to measuring cardiac troponins alone. Even firm detractors of this assumption shall now be persuaded that CK-MB and myoglobin must rest in peace for the diagnostics of acute cardiac injury
Anotace (abstract) Biomarkers diagnosing myocardial damages have recently been a very dynamically de...
AbstractThe diagnosis of myocardial necrosis due to acute myocardial infarction (AMI) and other caus...
Elucidation of the physiologically distinct subunits of troponin in 1973 greatly facilitated our und...
diagnosis of cardiac injury is necessary to limitthe extent of myocardial damage and to prevent and ...
Testing for the diagnosis of acute myocardial infarction and other diseases included in the spectrum...
Cardiac diseases are mainly caused by malfunction of or injuries to the hearts. Although significan...
The measurement of cardiac troponins (cTn) is recommended by all guidelines as the gold standard for...
Cardiac troponins (cTn) are considered to be the ‘gold standard’ biomarkers for the diagnosis of acu...
The release of cardiomyocyte components, i.e. biomarkers, into the bloodstream in higher than usual ...
© 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.Trop...
Analysis of cardiac troponin I (cTn I) and T (cTnT) are considered the “gold standard&...
Cardiac biomarkers such as CK-MB, troponins, and myoglobin provide the basis for the diagnosis of ac...
criteria2 their diagnosis would be reclassified as myocardial in-farction. We therefore agree that i...
Background Troponin measurements are now central to the diagnosis of acute coronary syndromes and fo...
The increased analytical sensitivity of the new generation of methods for cardiac troponin I (cTnI) ...
Anotace (abstract) Biomarkers diagnosing myocardial damages have recently been a very dynamically de...
AbstractThe diagnosis of myocardial necrosis due to acute myocardial infarction (AMI) and other caus...
Elucidation of the physiologically distinct subunits of troponin in 1973 greatly facilitated our und...
diagnosis of cardiac injury is necessary to limitthe extent of myocardial damage and to prevent and ...
Testing for the diagnosis of acute myocardial infarction and other diseases included in the spectrum...
Cardiac diseases are mainly caused by malfunction of or injuries to the hearts. Although significan...
The measurement of cardiac troponins (cTn) is recommended by all guidelines as the gold standard for...
Cardiac troponins (cTn) are considered to be the ‘gold standard’ biomarkers for the diagnosis of acu...
The release of cardiomyocyte components, i.e. biomarkers, into the bloodstream in higher than usual ...
© 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.Trop...
Analysis of cardiac troponin I (cTn I) and T (cTnT) are considered the “gold standard&...
Cardiac biomarkers such as CK-MB, troponins, and myoglobin provide the basis for the diagnosis of ac...
criteria2 their diagnosis would be reclassified as myocardial in-farction. We therefore agree that i...
Background Troponin measurements are now central to the diagnosis of acute coronary syndromes and fo...
The increased analytical sensitivity of the new generation of methods for cardiac troponin I (cTnI) ...
Anotace (abstract) Biomarkers diagnosing myocardial damages have recently been a very dynamically de...
AbstractThe diagnosis of myocardial necrosis due to acute myocardial infarction (AMI) and other caus...
Elucidation of the physiologically distinct subunits of troponin in 1973 greatly facilitated our und...